These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DELAWARE
|
|
46-4254555
|
|
(State or other jurisdiction of
|
|
(IRS employer
|
|
incorporation or organization)
|
|
Identification no.)
|
|
|
|
|
|
1400 FOUNTAINGROVE PARKWAY,
|
|
|
|
SANTA ROSA, CALIFORNIA
|
|
95403
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
¨
|
|
Accelerated filer
¨
|
|
|
|
|
|
Non-accelerated filer
x
|
|
Smaller reporting company
¨
|
|
(do not check if a smaller reporting company)
|
|
|
|
CLASS
|
|
OUTSTANDING AT JANUARY 31, 2015
|
|
COMMON STOCK, $0.01 PAR VALUE
|
|
168,450,545
|
|
|
|
|
Page
Number
|
|
|
|||
|
|
|||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|
||
|
|
|
||
|
|
— FINANCIAL INFORMATION
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Net revenue:
|
|
|
|
|
|
||
|
Products
|
$
|
596
|
|
|
$
|
563
|
|
|
Services and other
|
105
|
|
|
108
|
|
||
|
Total net revenue
|
701
|
|
|
671
|
|
||
|
Costs and expenses:
|
|
|
|
|
|
||
|
Cost of products
|
260
|
|
|
245
|
|
||
|
Cost of services and other
|
58
|
|
|
54
|
|
||
|
Total costs
|
318
|
|
|
299
|
|
||
|
Research and development
|
96
|
|
|
90
|
|
||
|
Selling, general and administrative
|
206
|
|
|
191
|
|
||
|
Total costs and expenses
|
620
|
|
|
580
|
|
||
|
Income from operations
|
81
|
|
|
91
|
|
||
|
Interest expense
|
(12
|
)
|
|
—
|
|
||
|
Other income (expense), net
|
9
|
|
|
1
|
|
||
|
Income before taxes
|
78
|
|
|
92
|
|
||
|
Provision for income taxes
|
8
|
|
|
18
|
|
||
|
Net income
|
$
|
70
|
|
|
$
|
74
|
|
|
|
|
|
|
||||
|
Net income per share:
(a)
|
|
|
|
|
|
||
|
Basic
|
$
|
0.42
|
|
|
$
|
0.44
|
|
|
Diluted
|
$
|
0.41
|
|
|
$
|
0.44
|
|
|
|
|
|
|
||||
|
Weighted average shares used in computing net income per share:
(a)
|
|
|
|
|
|
||
|
Basic
|
168
|
|
|
167
|
|
||
|
Diluted
|
170
|
|
|
167
|
|
||
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
|
|
|
||||
|
Net income
|
$
|
70
|
|
|
$
|
74
|
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Unrealized loss on investments, net of tax benefit of zero and $1
|
—
|
|
|
(2
|
)
|
||
|
Unrealized loss on derivative instruments, net of tax benefit of $2 and zero
|
(3
|
)
|
|
—
|
|
||
|
Amounts reclassified into earnings related to derivative instruments, net of tax expense of zero
|
(1
|
)
|
|
—
|
|
||
|
Foreign currency translation, net of tax benefit of zero and $1
|
(33
|
)
|
|
(12
|
)
|
||
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
||||
|
Change in actuarial net loss, net of tax expense of $(3) and zero
|
8
|
|
|
—
|
|
||
|
Change in net prior service benefit, net of tax benefit of $3 and zero
|
(4
|
)
|
|
—
|
|
||
|
Other comprehensive loss
|
(33
|
)
|
|
(14
|
)
|
||
|
Total comprehensive income
|
$
|
37
|
|
|
$
|
60
|
|
|
|
January 31,
2015 |
|
October 31,
2014 |
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
887
|
|
|
$
|
810
|
|
|
Accounts receivable, net
|
309
|
|
|
357
|
|
||
|
Receivable from Agilent
|
1
|
|
|
23
|
|
||
|
Inventory
|
477
|
|
|
498
|
|
||
|
Deferred tax assets
|
82
|
|
|
83
|
|
||
|
Other current assets
|
136
|
|
|
79
|
|
||
|
Total current assets
|
1,892
|
|
|
1,850
|
|
||
|
Property, plant and equipment, net
|
455
|
|
|
470
|
|
||
|
Goodwill
|
381
|
|
|
392
|
|
||
|
Other intangible assets, net
|
16
|
|
|
18
|
|
||
|
Long-term investments
|
59
|
|
|
63
|
|
||
|
Long-term deferred tax assets
|
135
|
|
|
163
|
|
||
|
Other assets
|
91
|
|
|
94
|
|
||
|
Total assets
|
$
|
3,029
|
|
|
$
|
3,050
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
$
|
158
|
|
|
$
|
173
|
|
|
Payable to Agilent
|
64
|
|
|
125
|
|
||
|
Employee compensation and benefits
|
146
|
|
|
167
|
|
||
|
Deferred revenue
|
176
|
|
|
175
|
|
||
|
Income and other taxes payable
|
60
|
|
|
72
|
|
||
|
Other accrued liabilities
|
96
|
|
|
57
|
|
||
|
Total current liabilities
|
700
|
|
|
769
|
|
||
|
Long-term debt
|
1,099
|
|
|
1,099
|
|
||
|
Retirement and post-retirement benefits
|
187
|
|
|
213
|
|
||
|
Long-term deferred revenue
|
66
|
|
|
69
|
|
||
|
Other long-term liabilities
|
59
|
|
|
131
|
|
||
|
Total liabilities
|
2,111
|
|
|
2,281
|
|
||
|
Commitments and contingencies (Note 12)
|
|
|
|
|
|
||
|
Total equity:
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
|
|
||
|
Preferred stock; $0.01 par value; 100 million shares authorized; none issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock; $0.01 par value; 1 billion shares authorized; 168 million shares at January 31, 2015 and 167 million shares at October 31, 2014 issued and outstanding
|
2
|
|
|
2
|
|
||
|
Additional paid-in-capital
|
1,114
|
|
|
1,002
|
|
||
|
Retained earnings
|
171
|
|
|
101
|
|
||
|
Accumulated other comprehensive loss
|
(369
|
)
|
|
(336
|
)
|
||
|
Total stockholders' equity
|
918
|
|
|
769
|
|
||
|
Total liabilities and equity
|
$
|
3,029
|
|
|
$
|
3,050
|
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||
|
Net income
|
$
|
70
|
|
|
$
|
74
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
23
|
|
|
19
|
|
||
|
Share-based compensation
|
29
|
|
|
17
|
|
||
|
Excess tax benefit from share-based plans
|
(3
|
)
|
|
—
|
|
||
|
Deferred taxes
|
(1
|
)
|
|
27
|
|
||
|
Excess and obsolete inventory related charges
|
10
|
|
|
6
|
|
||
|
Other non-cash expenses, net
|
(1
|
)
|
|
—
|
|
||
|
Changes in assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
36
|
|
|
49
|
|
||
|
Inventory
|
(9
|
)
|
|
(18
|
)
|
||
|
Accounts payable
|
(13
|
)
|
|
(1
|
)
|
||
|
Payment to Agilent, net
|
(14
|
)
|
|
—
|
|
||
|
Employee compensation and benefits
|
(22
|
)
|
|
(22
|
)
|
||
|
Other assets and liabilities
|
(13
|
)
|
|
(16
|
)
|
||
|
Net cash provided by operating activities
|
92
|
|
|
135
|
|
||
|
|
|
|
|
||||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Investments in property, plant and equipment
|
(15
|
)
|
|
(11
|
)
|
||
|
Proceeds from sale of investments
|
1
|
|
|
—
|
|
||
|
Net cash used in investing activities
|
(14
|
)
|
|
(11
|
)
|
||
|
|
|
|
|
||||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Issuance of common stock under employee stock plans
|
4
|
|
|
—
|
|
||
|
Net transfers to Agilent
|
—
|
|
|
(124
|
)
|
||
|
Excess tax benefit from share-based plans
|
3
|
|
|
—
|
|
||
|
Net cash provided by (used in) financing activities
|
7
|
|
|
(124
|
)
|
||
|
|
|
|
|
||||
|
Effect of exchange rate movements
|
(8
|
)
|
|
—
|
|
||
|
|
|
|
|
||||
|
Net increase in cash and cash equivalents
|
77
|
|
|
—
|
|
||
|
|
|
|
|
||||
|
Cash and cash equivalents at beginning of period
|
810
|
|
|
—
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
887
|
|
|
$
|
—
|
|
|
1.
|
OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
|
Three Months Ended
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Cost of products and services
|
$
|
—
|
|
|
$
|
25
|
|
|
Research and development
|
—
|
|
|
11
|
|
||
|
Selling, general and administrative
|
—
|
|
|
66
|
|
||
|
Other (income) expense, net
|
—
|
|
|
(1
|
)
|
||
|
Total allocated costs
|
$
|
—
|
|
|
$
|
101
|
|
|
|
January 31, 2015
|
|
October 31, 2014
|
||||
|
|
(in millions)
|
||||||
|
Receivable from Agilent
|
$
|
1
|
|
|
$
|
23
|
|
|
Payable to Agilent
|
$
|
64
|
|
|
$
|
125
|
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Cost of products and services
|
$
|
4
|
|
|
$
|
4
|
|
|
Research and development
|
4
|
|
|
3
|
|
||
|
Selling, general and administrative
|
21
|
|
|
10
|
|
||
|
Total share-based compensation expense
|
$
|
29
|
|
|
$
|
17
|
|
|
|
Three Months Ended
|
||||
|
|
January 31,
|
||||
|
|
2015
|
|
2014
|
||
|
Stock Option Plans:
|
|
|
|
|
|
|
Weighted average risk-free interest rate
|
1.6
|
%
|
|
1.7
|
%
|
|
Dividend yield
|
—
|
%
|
|
1
|
%
|
|
Weighted average volatility
|
31
|
%
|
|
39
|
%
|
|
Expected life
|
4.8 years
|
|
|
5.8 years
|
|
|
LTP Program
|
|
|
|
||
|
Volatility of Keysight shares
|
26
|
%
|
|
—
|
%
|
|
Volatility of selected peer-company shares
|
17%-67%
|
|
|
—
|
%
|
|
Price-wise correlation with selected peers
|
38
|
%
|
|
—
|
%
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Numerator:
|
|
|
|
|
|
||
|
Net income
|
$
|
70
|
|
|
$
|
74
|
|
|
Denominator:
|
|
|
|
||||
|
Basic weighted-average shares
(a)
|
168
|
|
|
167
|
|
||
|
Potential common shares— stock options and other employee stock plans
|
2
|
|
|
—
|
|
||
|
Diluted weighted-average shares
(a)
|
170
|
|
|
167
|
|
||
|
|
January 31,
2015 |
|
October 31,
2014 |
||||
|
|
(in millions)
|
||||||
|
Finished goods
|
$
|
225
|
|
|
$
|
219
|
|
|
Purchased parts and fabricated assemblies
|
252
|
|
|
279
|
|
||
|
Total Inventory
|
$
|
477
|
|
|
$
|
498
|
|
|
8.
|
GOODWILL AND OTHER INTANGIBLE ASSETS
|
|
|
Customer Support and Services
|
|
Measurement Solutions
|
|
Total
|
||||||
|
|
(in millions)
|
||||||||||
|
Goodwill as of October 31, 2014
|
$
|
55
|
|
|
$
|
337
|
|
|
$
|
392
|
|
|
Foreign currency translation impact
|
(1
|
)
|
|
(10
|
)
|
|
(11
|
)
|
|||
|
Goodwill as of January 31, 2015
|
$
|
54
|
|
|
$
|
327
|
|
|
$
|
381
|
|
|
|
Other Intangible Assets
|
||||||||||
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
and
Impairments
|
|
Net Book
Value
|
||||||
|
|
(in millions)
|
||||||||||
|
As of October 31, 2014:
|
|
|
|
|
|
|
|
|
|||
|
Developed technology
|
$
|
125
|
|
|
$
|
114
|
|
|
$
|
11
|
|
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
1
|
|
|
1
|
|
|
—
|
|
|||
|
Customer relationships
|
32
|
|
|
25
|
|
|
7
|
|
|||
|
Total
|
$
|
162
|
|
|
$
|
144
|
|
|
$
|
18
|
|
|
As of January 31, 2015:
|
|
|
|
|
|
|
|
|
|||
|
Developed technology
|
125
|
|
|
115
|
|
|
10
|
|
|||
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
1
|
|
|
1
|
|
|
—
|
|
|||
|
Customer relationships
|
32
|
|
|
26
|
|
|
6
|
|
|||
|
Total
|
$
|
162
|
|
|
$
|
146
|
|
|
$
|
16
|
|
|
|
|
|
Fair Value Measurement at January 31, 2015 Using
|
||||||||||||
|
|
January 31,
2015 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Short-term
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash equivalents (money market funds)
|
$
|
696
|
|
|
$
|
696
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivative instruments (foreign exchange contracts)
|
10
|
|
|
—
|
|
|
10
|
|
|
—
|
|
||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
12
|
|
|
12
|
|
|
—
|
|
|
—
|
|
||||
|
Available-for-sale investments
|
33
|
|
|
33
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
751
|
|
|
$
|
741
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Derivative instruments (foreign exchange contracts)
|
$
|
16
|
|
|
$
|
—
|
|
|
$
|
16
|
|
|
$
|
—
|
|
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
12
|
|
|
—
|
|
|
12
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
28
|
|
|
$
|
—
|
|
|
$
|
28
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Short-term
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash equivalents (money market funds)
|
$
|
634
|
|
|
$
|
634
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivative instruments (foreign exchange contracts)
|
9
|
|
|
—
|
|
|
9
|
|
|
—
|
|
||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
13
|
|
|
13
|
|
|
—
|
|
|
—
|
|
||||
|
Available-for-sale investments
|
35
|
|
|
35
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
691
|
|
|
$
|
682
|
|
|
$
|
9
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Derivative instruments (foreign exchange contracts)
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
16
|
|
|
$
|
—
|
|
|
$
|
16
|
|
|
$
|
—
|
|
|
10.
|
DERIVATIVES
|
|
|
|
Derivatives in Cash Flow
Hedging Relationships
|
|
Derivatives
Not
Designated
as Hedging
Instruments
|
||||||||
|
|
|
Forward
Contracts
|
|
Option
Contracts
|
|
Forward
Contracts
|
||||||
|
Currency
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
||||||
|
|
|
(in millions)
|
||||||||||
|
Euro
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
65
|
|
|
British Pound
|
|
—
|
|
|
—
|
|
|
45
|
|
|||
|
Singapore Dollar
|
|
12
|
|
|
—
|
|
|
13
|
|
|||
|
Malaysian Ringgit
|
|
84
|
|
|
—
|
|
|
13
|
|
|||
|
Japanese Yen
|
|
(94
|
)
|
|
(5
|
)
|
|
(31
|
)
|
|||
|
Other
|
|
(9
|
)
|
|
—
|
|
|
9
|
|
|||
|
Totals
|
|
$
|
(7
|
)
|
|
$
|
(5
|
)
|
|
$
|
114
|
|
|
Fair Values of Derivative Instruments
|
||||||||||||||||||
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||||||||||
|
|
|
Fair Value
|
|
|
|
Fair Value
|
||||||||||||
|
Balance Sheet Location
|
|
January 31,
2015 |
|
October 31,
2014 |
|
Balance Sheet Location
|
|
January 31,
2015 |
|
October 31,
2014 |
||||||||
|
(in millions)
|
||||||||||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash flow hedges
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current assets
|
|
$
|
8
|
|
|
$
|
7
|
|
|
Other accrued liabilities
|
|
$
|
8
|
|
|
$
|
1
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Other current assets
|
|
2
|
|
|
2
|
|
|
Other accrued liabilities
|
|
8
|
|
|
2
|
|
||||
|
Total derivatives
|
|
$
|
10
|
|
|
$
|
9
|
|
|
|
|
$
|
16
|
|
|
$
|
3
|
|
|
|
|||||||
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
||
|
Cash Flow Hedges
|
|
|
|
||||
|
Foreign exchange contracts:
|
|
|
|
||||
|
Loss recognized in accumulated other comprehensive income
|
$
|
(5
|
)
|
|
$
|
—
|
|
|
Gain reclassified from accumulated other comprehensive income into cost of sales
|
$
|
1
|
|
|
$
|
—
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
||||
|
Loss recognized in other income (expense), net
|
$
|
(6
|
)
|
|
$
|
—
|
|
|
|
Pensions
|
|
|
||||||||||||||||||||
|
|
U.S. Defined Benefit Plans
|
|
Non-U.S. Defined Benefit
Plans
|
|
U.S. Post-Retirement
Benefit Plan
|
||||||||||||||||||
|
|
Three Months Ended January 31,
|
||||||||||||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
Service cost—benefits earned during the period
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Interest cost on benefit obligation
|
5
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||||
|
Expected return on plan assets
|
(9
|
)
|
|
—
|
|
|
(19
|
)
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
||||||
|
Amortization:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net actuarial losses
|
1
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
3
|
|
|
—
|
|
||||||
|
Prior service credit
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
||||||
|
Allocated benefit cost from Agilent
|
—
|
|
|
1
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||||
|
Total periodic benefit cost (benefit)
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
3
|
|
|
$
|
3
|
|
|
$
|
(4
|
)
|
|
$
|
3
|
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Beginning balance as of November 1
|
$
|
51
|
|
|
$
|
38
|
|
|
Accruals for warranties including change in estimate
|
9
|
|
|
12
|
|
||
|
Settlements made during the period
|
(9
|
)
|
|
(8
|
)
|
||
|
Ending balance as of January 31
|
$
|
51
|
|
|
$
|
42
|
|
|
|
|
|
|
||||
|
Accruals for warranties due within one year
|
$
|
36
|
|
|
$
|
24
|
|
|
Accruals for warranties due after one year
|
15
|
|
|
18
|
|
||
|
Ending balance as of January 31
|
$
|
51
|
|
|
$
|
42
|
|
|
|
January 31, 2015
|
|
October 31, 2014
|
||||
|
|
(in millions)
|
||||||
|
3.30% Senior Notes due 2019
|
$
|
499
|
|
|
$
|
499
|
|
|
4.55% Senior Notes due 2024
|
600
|
|
|
600
|
|
||
|
Total
|
$
|
1,099
|
|
|
$
|
1,099
|
|
|
|
|
|
|
|
|
Net defined benefit pension cost and post retirement plan costs
|
|
|
|
|
||||||||||||||
|
|
|
Unrealized gain on investments
|
|
Foreign currency translation
|
|
Actuarial losses
|
|
Prior service costs
|
|
Unrealized gains (losses) on derivatives
|
|
Total
|
||||||||||||
|
|
|
(in millions)
|
||||||||||||||||||||||
|
As of October 31, 2014
|
|
$
|
16
|
|
|
$
|
6
|
|
|
$
|
(444
|
)
|
|
$
|
83
|
|
|
$
|
3
|
|
|
$
|
(336
|
)
|
|
Other comprehensive loss before reclassifications
|
|
—
|
|
|
(33
|
)
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
(38
|
)
|
||||||
|
Amounts reclassified out of accumulated other comprehensive income
|
|
—
|
|
|
—
|
|
|
11
|
|
|
(7
|
)
|
|
(1
|
)
|
|
3
|
|
||||||
|
Tax (expense) benefit
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
3
|
|
|
2
|
|
|
2
|
|
||||||
|
Other comprehensive income (loss)
|
|
—
|
|
|
(33
|
)
|
|
8
|
|
|
(4
|
)
|
|
(4
|
)
|
|
(33
|
)
|
||||||
|
As of January 31, 2015
|
|
$
|
16
|
|
|
$
|
(27
|
)
|
|
$
|
(436
|
)
|
|
$
|
79
|
|
|
$
|
(1
|
)
|
|
$
|
(369
|
)
|
|
Details about Accumulated Other Comprehensive Loss Components
|
|
Amounts Reclassified from Other Comprehensive Loss
|
|
Affected Line Item in Statement of Operations
|
||||||
|
|
|
Three Months Ended
|
|
|
||||||
|
|
|
January 31,
|
|
|
||||||
|
|
|
2015
|
|
2014
|
|
|
||||
|
|
|
(in millions)
|
|
|
||||||
|
Unrealized gain on derivatives
|
|
$
|
1
|
|
|
$
|
—
|
|
|
Cost of products
|
|
|
|
—
|
|
|
—
|
|
|
Provision for income taxes
|
||
|
|
|
1
|
|
|
—
|
|
|
Net of income tax
|
||
|
|
|
|
|
|
|
|
||||
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
|
|
||||
|
Actuarial net loss
|
|
(11
|
)
|
|
—
|
|
|
|
||
|
Prior service benefit
|
|
7
|
|
|
—
|
|
|
|
||
|
|
|
(4
|
)
|
|
—
|
|
|
Total before income tax
|
||
|
|
|
—
|
|
|
—
|
|
|
Provision for income taxes
|
||
|
|
|
(4
|
)
|
|
—
|
|
|
Net of income tax
|
||
|
|
|
|
|
|
|
|
||||
|
Total reclassifications for the period
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
|
|
|
Measurement Solutions
|
|
Customer Support and Services
|
|
Total Segments
|
||||||
|
|
(in millions)
|
||||||||||
|
Three Months Ended January 31, 2015:
|
|
|
|
|
|
|
|
|
|||
|
Total net revenue
|
$
|
606
|
|
|
$
|
95
|
|
|
$
|
701
|
|
|
Segment income from operations
|
$
|
107
|
|
|
$
|
13
|
|
|
$
|
120
|
|
|
Three months ended January 31, 2014:
|
|
|
|
|
|
|
|
|
|||
|
Total net revenue
|
$
|
574
|
|
|
$
|
97
|
|
|
$
|
671
|
|
|
Segment income from operations
|
$
|
99
|
|
|
$
|
19
|
|
|
$
|
118
|
|
|
|
Three Months Ended
|
||||||
|
|
January 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Total reportable segment income from operations
|
$
|
120
|
|
|
$
|
118
|
|
|
Share based compensation expense
|
(29
|
)
|
|
(17
|
)
|
||
|
Restructuring-related costs
|
—
|
|
|
3
|
|
||
|
Transformational programs
|
—
|
|
|
(1
|
)
|
||
|
Amortization of intangibles
|
(2
|
)
|
|
(2
|
)
|
||
|
Acquisition and integration costs
|
—
|
|
|
(1
|
)
|
||
|
Separation related costs
|
(7
|
)
|
|
(8
|
)
|
||
|
Other
|
(1
|
)
|
|
(1
|
)
|
||
|
Interest expense
|
(12
|
)
|
|
—
|
|
||
|
Other income (expense), net
|
9
|
|
|
1
|
|
||
|
Income before taxes, as reported
|
$
|
78
|
|
|
$
|
92
|
|
|
|
Measurement Solutions
|
|
Customer Support and Services
|
|
Total
|
||||||
|
|
(in millions)
|
||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|||
|
As of January 31, 2015
|
$
|
1,577
|
|
|
$
|
214
|
|
|
$
|
1,791
|
|
|
As of October 31, 2014
|
$
|
1,740
|
|
|
$
|
236
|
|
|
$
|
1,976
|
|
|
|
Three Months Ended
|
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
|
Months
|
||||
|
|
(in millions)
|
|
|
|||||||
|
Orders
|
$
|
691
|
|
|
$
|
699
|
|
|
|
(1)%
|
|
Net revenue:
|
|
|
|
|
|
|
||||
|
Products
|
$
|
596
|
|
|
$
|
563
|
|
|
|
6%
|
|
Services and other
|
105
|
|
|
108
|
|
|
|
(3)%
|
||
|
Total net revenue
|
$
|
701
|
|
|
$
|
671
|
|
|
|
4%
|
|
|
Three Months Ended
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
Months
|
||||
|
|
($ in millions)
|
|
|
||||||
|
Gross margin
|
54.6
|
%
|
|
55.4
|
%
|
|
(1) ppt
|
||
|
Operating margin
|
11.6
|
%
|
|
13.6
|
%
|
|
(2) ppts
|
||
|
|
|
|
|
|
|
||||
|
Research and development
|
$
|
96
|
|
|
$
|
90
|
|
|
7%
|
|
Selling, general and administrative
|
$
|
206
|
|
|
$
|
191
|
|
|
8%
|
|
|
|||||||||
|
|
Three Months Ended
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
Months
|
||||
|
|
(in millions)
|
|
|
||||||
|
Net revenue
|
$
|
606
|
|
|
$
|
574
|
|
|
6%
|
|
|
Three Months Ended
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
Months
|
||||
|
|
($ in millions)
|
|
|
||||||
|
Total gross margin
|
57.6
|
%
|
|
57.8
|
%
|
|
—
|
||
|
Operating margin
|
17.7
|
%
|
|
17.2
|
%
|
|
1 ppt
|
||
|
|
|
|
|
|
|
||||
|
Research and development
|
$
|
89
|
|
|
$
|
85
|
|
|
5%
|
|
Selling, general and administrative
|
$
|
153
|
|
|
$
|
148
|
|
|
4%
|
|
Income from operations
|
$
|
107
|
|
|
$
|
99
|
|
|
9%
|
|
|
Three Months Ended
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
Months
|
||||
|
|
(in millions)
|
|
|
||||||
|
Net revenue
|
$
|
95
|
|
|
$
|
97
|
|
|
(2)%
|
|
|
Three Months Ended
|
|
Year over Year Change
|
||||||
|
|
January 31,
|
|
Three
|
||||||
|
|
2015
|
|
2014
|
|
Months
|
||||
|
|
($ in millions)
|
|
|
||||||
|
Total gross margin
|
42.0
|
%
|
|
46.3
|
%
|
|
(4) ppts
|
||
|
Operating margin
|
13.7
|
%
|
|
20.0
|
%
|
|
(6) ppts
|
||
|
|
|
|
|
|
|
||||
|
Research and development
|
$
|
3
|
|
|
$
|
3
|
|
|
—%
|
|
Selling, general and administrative
|
$
|
24
|
|
|
$
|
23
|
|
|
4%
|
|
Income from operations
|
$
|
13
|
|
|
$
|
19
|
|
|
(33)%
|
|
•
|
reduced demand for our products, delays in the shipment of orders or increases in order cancellations;
|
|
•
|
increased risk of excess and obsolete inventories;
|
|
•
|
increased price pressure for our products and services; and
|
|
•
|
greater risk of impairment to the value, and a detriment to the liquidity, of our future investment portfolio.
|
|
•
|
properly identify customer needs;
|
|
•
|
innovate and develop new technologies, services and applications;
|
|
•
|
successfully commercialize new technologies in a timely manner;
|
|
•
|
manufacture and deliver our products in sufficient volumes and on time;
|
|
•
|
differentiate our offerings from our competitors' offerings;
|
|
•
|
price our products competitively;
|
|
•
|
anticipate our competitors' development of new products, services or technological innovations; and control product quality in our manufacturing process.
|
|
•
|
interruption to transportation flows for delivery of parts to us and finished goods to our customers;
|
|
•
|
changes in foreign currency exchange rates;
|
|
•
|
changes in a specific country's or region's political, economic or other conditions;
|
|
•
|
trade protection measures, sanctions, and import or export licensing requirements or restrictions;
|
|
•
|
negative consequences from changes in tax laws;
|
|
•
|
difficulty in staffing and managing widespread operations;
|
|
•
|
differing labor regulations;
|
|
•
|
differing protection of intellectual property;
|
|
•
|
unexpected changes in regulatory requirements; and
|
|
•
|
volatile political environments or geopolitical turmoil, including regional conflicts, terrorism, and war.
|
|
•
|
the retention of key employees and/or customers;
|
|
•
|
the management of facilities and employees in different geographic areas; and
|
|
•
|
the compatibility of our infrastructure, policies and organizations with those of the acquired company.
|
|
•
|
requiring a portion of our cash flow from operations to make interest payments on this debt;
|
|
•
|
increasing our vulnerability to general adverse economic and industry conditions;
|
|
•
|
reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business; and
|
|
•
|
limiting our flexibility in planning for, or reacting to, changes in our business and the industry.
|
|
•
|
prior to the separation, our business was operated by Agilent as part of its broader corporate organization, rather than as an independent company. Agilent or one of its affiliates performed various corporate functions for us such as legal, treasury, accounting, auditing, human resources, corporate affairs and finance. Our historical financial results reflect allocations of corporate expenses from Agilent for such functions and are likely to be less than the expenses we would have incurred had we operated as a separate publicly-traded company. Following the separation, our cost related to such functions previously performed by Agilent may therefor increase;
|
|
•
|
our business was integrated with the other businesses of Agilent. Historically, we shared economies of scope and scale in costs, employees, vendor relationships and customer relationships. Although our transition agreements with Agilent took effect upon the separation, these arrangements may not fully capture the benefits that we enjoyed as a result of being integrated with Agilent and may result in the company paying higher charges than in the past for these services. This could have an adverse effect on our results of operations and financial condition following the separation;
|
|
•
|
generally, our working capital requirements and capital for our general corporate purposes, including acquisitions and capital expenditures, have historically been satisfied as part of the corporate-wide cash management policies of Agilent. Following the separation, we may need to obtain additional financing from banks, through public offerings or private placements of debt or equity securities, strategic relationships or other arrangements;
|
|
•
|
after the separation, the cost of capital for our business may be higher than Agilent's cost of capital prior to the separation; and
|
|
•
|
our historical financial information does not reflect the debt or the associated interest expense that we have incurred as part of the separation and distribution.
|
|
•
|
a distinct investment identity allowing investors to evaluate the merits, performance and future prospects of Keysight separately from Agilent;
|
|
•
|
more effective pursuit of each company's distinct operating priorities and strategies;
|
|
•
|
more efficient allocation of capital for both Agilent and Keysight;
|
|
•
|
direct access by Keysight to the capital markets; and
|
|
•
|
facilitation of incentive compensation arrangements for employees more directly tied to the performance of the relevant company's business, and potential enhancement of employee hiring and retention by, among other things, improving the alignment of management and employee incentives with performance and growth objectives, while at the same time creating an independent equity structure that will facilitate our ability to affect future acquisitions utilizing Keysight common stock.
|
|
•
|
was insolvent;
|
|
•
|
was rendered insolvent by reason of the separation and distribution;
|
|
•
|
had remaining assets constituting unreasonably small capital; or
|
|
•
|
intended to incur, or believed it would incur, debts beyond its ability to pay these debts as they matured,
|
|
•
|
actual or anticipated fluctuations in our operating results due to factors related to our business;
|
|
•
|
success or failure of our business strategy;
|
|
•
|
our quarterly or annual earnings, or those of other companies in our industry;
|
|
•
|
our ability to obtain third-party financing as needed;
|
|
•
|
announcements by us or our competitors of significant acquisitions or dispositions;
|
|
•
|
changes in accounting standards, policies, guidance, interpretations or principles;
|
|
•
|
the failure of securities analysts to cover our common stock;
|
|
•
|
changes in earnings estimates by securities analysts or our ability to meet those estimates;
|
|
•
|
the operating and share price performance of other comparable companies;
|
|
•
|
investor perception of our company;
|
|
•
|
natural or other disasters that investors believe may affect us;
|
|
•
|
overall market fluctuations;
|
|
•
|
results from any material litigation or government investigations;
|
|
•
|
changes in laws or regulations affecting our business; and
|
|
•
|
general economic conditions and other external factors.
|
|
•
|
the inability of our shareholders to call a special meeting;
|
|
•
|
the inability of our shareholders to act without a meeting of shareholders;
|
|
•
|
rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings;
|
|
•
|
the right of our board to issue preferred stock without shareholder approval;
|
|
•
|
the division of our board of directors into three classes of directors, with each class serving a staggered three-year term, and this classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult;
|
|
•
|
a provision that shareholders may only remove directors with cause;
|
|
•
|
the ability of our directors, and not shareholders, to fill vacancies on our board of directors; and
|
|
•
|
the requirement that the affirmative vote of shareholders holding at least 80% of our voting stock is required to amend certain provisions in our amended and restated certificate of incorporation (relating to the number, term and removal of our directors, the filling of our board vacancies, the advance notice to be given for nominations for elections of directors, the calling of special meetings of shareholders, shareholder action by written consent, the ability of the board of directors to amend the bylaws, elimination of liability of directors to the extent permitted by Delaware law, exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders and amendments of the certificate of incorporation) and certain provisions in our amended and restated bylaws (relating to the calling of special meetings of shareholders, the business that may be conducted or considered at annual or special meetings, the advance notice of shareholder business
|
|
Dated:
|
March 5, 2015
|
By:
|
/s/ Neil Dougherty
|
|
|
|
|
Neil Dougherty
|
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
|
|
|
|
Dated:
|
March 5, 2015
|
By:
|
/s/ John Skinner
|
|
|
|
|
John Skinner
|
|
|
|
|
Vice President and Corporate Controller
|
|
|
|
|
(Principal Accounting Officer)
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
|
11.1
|
|
|
See Note 6, “Net Income Per Share,” to our Condensed Combined and Consolidated Financial Statements.
|
|
|
|
|
|
|
21.1
|
|
|
List of Significant Subsidiaries of Keysight Technologies, Inc.
|
|
|
|
|
|
|
31.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
31.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
32.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
32.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|